中华消化杂志
中華消化雜誌
중화소화잡지
Chinese Journal of Digestion
2013年
4期
269-273
,共5页
孙菁%房静远%盛剑秋%谢鹏雁%张亚历%季峰%蔡建庭%胡乃中%李岩
孫菁%房靜遠%盛劍鞦%謝鵬雁%張亞歷%季峰%蔡建庭%鬍迺中%李巖
손정%방정원%성검추%사붕안%장아력%계봉%채건정%호내중%리암
消化不良%胃肠病用药(中药)%奥美拉唑%药物疗法,联合%多中心研究
消化不良%胃腸病用藥(中藥)%奧美拉唑%藥物療法,聯閤%多中心研究
소화불량%위장병용약(중약)%오미랍서%약물요법,연합%다중심연구
Dyspepsia%Gastrointestinal agents (traditional Chinese medicine)%Omeprazole%Drug therapy,combination%Multicenter study
目的 评价三九胃泰颗粒与奥美拉唑联合应用治疗功能性消化不良的疗效和安全性.方法采用多中心、随机、双盲、双模拟、平行对照设计.将405例功能性消化不良患者分为三九胃泰组、奥美拉唑组和联合用药组,每组135例,分别给予三九胃泰颗粒+奥美拉唑模拟剂、奥美拉唑十三九胃泰颗粒模拟剂和三九胃泰颗粒+奥美拉唑.各组均连续服药14d.观察各组治疗后临床症状的改善情况和不良反应.计量资料行Kruskal-Wallis H秩和检验.计数资料行卡方检验或Fisher确切概率法检验.三组间的两两比较,其检验水准α'=0.0125.结果治疗14 d后,三组患者临床症状均得到显著改善,三九胃泰组、奥美拉唑组、联合用药组的总有效率分别为69.2%(90/130)、65.6%(86/131)、83.7%(103/123).联合用药组的总有效率高于三九胃泰组和奥美拉唑组(x2=7.3543和10.9033,P=0.0067和0.0010),三九胃泰组与奥美拉唑组比较差异无统计学意义(P>0.05).不良反应主要为头晕、嗜睡、烧心、腹痛、ALT升高等,三组的不良反应发生率差异无统计学意义(P>0.05).结论 三九胃泰颗粒与奥美拉唑联用治疗功能性消化不良的综合疗效显著,且不良反应少.
目的 評價三九胃泰顆粒與奧美拉唑聯閤應用治療功能性消化不良的療效和安全性.方法採用多中心、隨機、雙盲、雙模擬、平行對照設計.將405例功能性消化不良患者分為三九胃泰組、奧美拉唑組和聯閤用藥組,每組135例,分彆給予三九胃泰顆粒+奧美拉唑模擬劑、奧美拉唑十三九胃泰顆粒模擬劑和三九胃泰顆粒+奧美拉唑.各組均連續服藥14d.觀察各組治療後臨床癥狀的改善情況和不良反應.計量資料行Kruskal-Wallis H秩和檢驗.計數資料行卡方檢驗或Fisher確切概率法檢驗.三組間的兩兩比較,其檢驗水準α'=0.0125.結果治療14 d後,三組患者臨床癥狀均得到顯著改善,三九胃泰組、奧美拉唑組、聯閤用藥組的總有效率分彆為69.2%(90/130)、65.6%(86/131)、83.7%(103/123).聯閤用藥組的總有效率高于三九胃泰組和奧美拉唑組(x2=7.3543和10.9033,P=0.0067和0.0010),三九胃泰組與奧美拉唑組比較差異無統計學意義(P>0.05).不良反應主要為頭暈、嗜睡、燒心、腹痛、ALT升高等,三組的不良反應髮生率差異無統計學意義(P>0.05).結論 三九胃泰顆粒與奧美拉唑聯用治療功能性消化不良的綜閤療效顯著,且不良反應少.
목적 평개삼구위태과립여오미랍서연합응용치료공능성소화불량적료효화안전성.방법채용다중심、수궤、쌍맹、쌍모의、평행대조설계.장405례공능성소화불량환자분위삼구위태조、오미랍서조화연합용약조,매조135례,분별급여삼구위태과립+오미랍서모의제、오미랍서십삼구위태과립모의제화삼구위태과립+오미랍서.각조균련속복약14d.관찰각조치료후림상증상적개선정황화불량반응.계량자료행Kruskal-Wallis H질화검험.계수자료행잡방검험혹Fisher학절개솔법검험.삼조간적량량비교,기검험수준α'=0.0125.결과치료14 d후,삼조환자림상증상균득도현저개선,삼구위태조、오미랍서조、연합용약조적총유효솔분별위69.2%(90/130)、65.6%(86/131)、83.7%(103/123).연합용약조적총유효솔고우삼구위태조화오미랍서조(x2=7.3543화10.9033,P=0.0067화0.0010),삼구위태조여오미랍서조비교차이무통계학의의(P>0.05).불량반응주요위두훈、기수、소심、복통、ALT승고등,삼조적불량반응발생솔차이무통계학의의(P>0.05).결론 삼구위태과립여오미랍서련용치료공능성소화불량적종합료효현저,차불량반응소.
Objective To evaluate the efficacy and safety of sanjiuweitai particles combined with omeprazole in the treatment of functional dyspepsia (FD).Methods A multicenter,randomized,double-blind,double-dummy,parallel-controlled clinical trial was carried out.A total of 405 FD patients were divided into sanjiuweitai group,omeprazole group and combination group.There were 135 cases in each group and were treated with sanjiuweitai particle and omeprazole simulant,omeprazole and sanjiuweitai particle stimulant and sanjiuweitai particle and omeprazole respectively.The medicine was continuously taken for 14 days.The improvement of clinical symptoms of each group was evaluated before and after treatment.Kruskal-Wallis H test was performed for measurement data.Chi-square test or Fisher exact probability method was used for counting material.Pairwise comparisons among three groups,the inspection level was α'=0.0125.Results Two weeks after treatment,clinical symptoms of all the three groups improved significantly.The total efficiency of sanjiuweitai group was 69.2 % (90/130),omeprazole group was 65.6 % (86/131) and combination group was 83.7% (103/123).The total efficiency of combination group was higher than those of sanjiuweitai and omeprazole group (x2 =7.3543 and10.9033,P=0.0067 and 0.0010).The total efficiency of sanjiuweitai group was equal with that of omeprazole group (P>0.05).The main adverse reaction included dizziness,sleepiness,heartburn,abdominal pain and ALT increase.There were no significant differences in the incidence of adverse events among three groups (P>0.05).Conclusion The efficacy of sanjiuweitai particles with omeprazole combination in the treatment of FD was significant and with few adverse reactions.